Netflix Inc. (NFLX) shares rose more than 5% on Friday, outperforming the broader market. Investors assessed the streaming giant’s growing investments in live sports programming and artificial intelligence initiatives as potential drivers of long-term growth and user engagement. The S&P 500 gained 0.3% while the Nasdaq Composite was up 0.06%. Investors appeared encouraged by Netflix’s
Sellas Life Sciences (SLS) shares are extending gains on Jun. 26 following a key regulatory filing that disclosed a series of comprehensive corporate amendments regarding executive compensation and protection. Specifically, the board restructured change-of-control and severance agreements for CEO Angelos Stergiou, CFO John Burns, and CDO Dragan Cicic. The marketplace is widely interpreting these sudden
Around two weeks ago, Elon Musk’s SpaceX conglomerate went public. Everyone who is remotely interested has a fair idea of the numbers. But in a nutshell, it was easily the biggest Initial Public Offering (IPO) in history. It also led to Mr Musk becoming the first ever trillionaire, however briefly. Without doubt, the whole SpaceX
Shares of SpaceX (SPCX) rose 3% on Friday as investors prepared for the company’s addition to the Russell 1000 Index. The move is expected to drive demand from passive investment funds and broaden the stock’s presence across major benchmarks. The gains came after a difficult stretch for the newly public company. The stock surged to
Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard. Investors are bailing on OMER mostly because the European Medicines Agency’s (EMA) expert panel has rejected its primary commercial asset. At the time of writing, Omeros stock is down some 50% versus the
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains followed the company’s Science Day presentation and investor event, where Moderna outlined an ambitious strategy to expand beyond its COVID-19 vaccine business and
Apple Inc. (AAPL) shares have come under pressure after the company raised prices on several MacBook and iPad models. But some Wall Street analysts believe the pullback could present a buying opportunity as the company leverages its pricing power and loyal customer base. Apple stock fell 6.1% on Thursday after the company announced price increases
The Dow Jones Industrial Average and the broader US stock market closed lower on Friday as investors continued rotating out of technology and semiconductor stocks while shifting into more defensive sectors such as healthcare, consumer staples, and utilities. The S&P 500 slipped 0.27% to close at 7,337.68, while the Nasdaq Composite fell 0.48% to 25,236.88.
The artificial intelligence boom has long been pitched as a transformative force that would boost productivity and eventually lower costs across the economy. But this week, investors were confronted with a less discussed consequence of the AI race: higher prices. Apple and Microsoft both announced product price increases on Thursday, citing soaring costs for memory
A growing chorus of China’s most influential hedge fund managers is sounding the alarm on what they describe as a dangerously overheated global AI trade. After an explosive run-up in semiconductor and model‑development stocks from Seoul to Silicon Valley, several of Beijing’s money managers now argue the rally has detached from fundamentals – and that